Bank of Maharashtra Q1 PAT ₹2,021 Cr up 27%; one-off flatters core to ~13%, NIM softens QoQ
PAT +26.83% YoY · revenue +13.9% · margins expanding
₹8,034.65 Cr
+13.9% YoY
₹2,020.54 Cr
+26.83% YoY
22.29%
+2.1pp YoY
₹2.63
Bank of Maharashtra reported consolidated net profit of ₹2,020.54 Cr for Q1 FY27 (standalone ₹2,020.19 Cr — the two are effectively identical), up 26.8% YoY from ₹1,593.09 Cr but essentially flat sequentially (+0.3% QoQ vs ₹2,014.46 Cr). The headline growth is flattered by a one-off: the bank reversed ₹250 Cr of COVID-19 contingency provisions during the quarter (it still holds a ₹760 Cr buffer). Stripping the write-back out on a like-for-like basis, underlying PAT growth is roughly +13% YoY — broadly in line with the ~14% topline expansion rather than the reported 27%.
Q1 FY-2027 vs prior quarters
The clean operating story is stronger than the flattered bottom line: pre-provision operating profit rose 21.3% YoY to ₹3,117.63 Cr and net interest income grew ~14.5% to ₹3,770 Cr, on interest earned of ₹8,034.65 Cr (+13.9% YoY) and total income of ₹9,063.53 Cr (+15% YoY). That said, margins softened sequentially — NIM eased to 3.79% from 3.95% in Q4 and 3.85% a year ago — the "sequential margin softness" flagged around the board meeting; the YoY lift in reported net profit margin (to 22.32% from 19.31%) owes partly to the provision reversal and a lower year-ago tax base, not pure spread expansion. The July 24 MCLR revision and deposit repricing are the swing factors for the NIM trajectory from here.
The stock went into the print at ₹80.26, up 2.3% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 5 consecutive quarters; revenue is at a 6-quarter high.
Management reiterated confidence in meeting and exceeding previously provided guidance across growth, profitability, and asset quality parameters. While maintaining the 18% loan growth guidance for FY27, the bank demonstrated a robust 27% year-on-year advance growth in Q1. Deposit growth remained healthy at 13% YoY, wi
— This quarter: beat
Balance-sheet momentum ran well ahead of guidance. Global advances grew ~27% YoY to ₹3.06 lakh Cr against management's 18% FY27 loan-growth guide, deposits rose ~13% to ₹3.44 lakh Cr, and total business was up 19% to ₹6.51 lakh Cr. Asset quality improved further — gross NPA down to 1.45% (from 1.74% YoY), net NPA at 0.13%, PCR 98.55%, ROA 1.90% and CAR 18.64% — confirming the confident, low-risk tone management struck on the results call. We could not find a published pre-result consensus estimate; post-result coverage characterised the print as "robust" and the stock rallied ~3% on the day. Board/management churn was minor and non-financial (director appointment on Aug 13; CCO resignation on Jul 24 with a successor pending).
W1
NIM trajectory: fell to 3.79% from 3.95% QoQ; impact of the Jul-24 MCLR revision and deposit repricing on Q2 spreads
W2
Provision buffer: ₹760 Cr COVID contingency still held after the ₹250 Cr reversal — whether further write-backs keep flattering reported PAT
W3
Loan growth vs the 18% FY27 guide: advances already +27% YoY; whether deposit growth (13%) keeps pace to fund it
Bank-format P&L in ₹Lakh, converted to ₹Cr. Revenue = Interest earned (matches our records). Consolidated PAT ₹2,020.54 Cr (net profit for period); after +₹2.78 Cr associate share, ₹2,023.32 Cr. Standalone/consolidated essentially identical (<0.02% divergence). One-off: ₹250 Cr COVID-19 contingency provision write-back this quarter (₹760 Cr buffer retained); effective tax rose to 11.3% from ~6.5% YoY. totalExpenses = income − PBT (incl. provisions). Arithmetic ties.
Informational and educational content only. Not investment advice.